This site is intended for healthcare professionals
Utrogestan (progesterone) is a progestogen indicated for the adjunctive use with oestrogen in postmenopausal women with an intact uterus.
The recommended dose is 200mg daily at bedtime, for 12 days, from day 15 to day 26 of each cycle. Withdrawal bleeding may occur in the following week.
Alternatively 100mg can be given at bedtime from day one to day 25 of each cycle, withdrawal bleeding being less with this treatment schedule.
Further information: Ferring 01753 214800
Go to: Utrogestan MIMS drug entry
The most up-to-date drug information at your fingertips.
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
Use our timeline to follow the latest coronavirus developments...
A global phase III clinical trial to evaluate an inhaled...
Use our constantly updated shortages tracker to check...
Myopridin (pridinol) can be prescribed to treat skeletal...
Drugs
Conditions
News and resources
MIMS Hosted